New study tests cheaper h. pylori treatment to beat antibiotic resistance
NCT ID NCT07574983
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two 14-day treatments for H. pylori, a stomach bacteria that can cause ulcers and cancer. About 90 adults will receive either a levofloxacin-based sequential therapy or a bismuth-based quadruple therapy. The goal is to see which treatment works better and has fewer side effects, aiming to find an affordable option for areas with high antibiotic resistance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Levofloxacin-based sequential therapy (dexlansoprazole, amoxicillin, levofloxacin, tinidazole) and bismuth-based quadruple therapy (bismuth subsalicylate, dexlansoprazole)
What this could lead to
If successful, this could identify a more effective and affordable first-line treatment for H. pylori infection, especially in areas with high antibiotic resistance.
What could go wrong
This is a small, early-stage trial with only 90 participants, so results may not apply to everyone. Both treatments can cause side effects like nausea or diarrhea, and antibiotic resistance may still limit effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••